Literature DB >> 16825292

The homeoprotein Alx3 expressed in pancreatic beta-cells regulates insulin gene transcription by interacting with the basic helix-loop-helix protein E47.

Mercedes Mirasierra1, Mario Vallejo.   

Abstract

The regulation of insulin gene expression in pancreatic beta-cells is the result of the coordinate activity of specific combinations of transcription factors assembled on different promoter elements. We investigated the involvement of the aristaless-related homeoprotein Alx3 in this process. We found that Alx3 is coexpressed with insulin in pancreatic islets, as well as in the beta-cell line MIN6, and it is also present in glucagon- and somatostatin-expressing cells. Chromatin immunoprecipitation assays indicated that Alx3 present in MIN6 cells and in mouse pancreatic islets occupies the promoter of the mouse insulin genes. EMSAs indicated that Alx3 present in MIN6 cells binds to the A3/4 regulatory element of the insulin I promoter. We found that Alx3 transactivates the insulin promoter by acting on the E2A3/4 enhancer in conjunction with the basic helix-loop-helix transcription factors E47/Pan1 and Beta2/NeuroD, and that Alx3 physically interacts via the homeodomain with E47/Pan1 but not with Beta2/NeuroD. Alx3 binds to the A3/4 element as a dimer, and the homeodomain is sufficient to recruit E47/Pan1 to the insulin promoter. Deletion studies in transfected HeLa cells indicated that proline-rich regions located at either side of the Alx3 homeodomain work together with E47/Pan1, and that this requires the integrity of the amino-terminal activation domain to transactivate. Thus, these studies support the notion that Alx3 participates in the regulation of insulin gene expression in pancreatic beta-cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16825292     DOI: 10.1210/me.2005-0472

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  7 in total

1.  Cx36 is a target of Beta2/NeuroD1, which associates with prenatal differentiation of insulin-producing β cells.

Authors:  Rachel Nlend Nlend; Aouatef Aït-Lounis; Florent Allagnat; Valentina Cigliola; Anne Charollais; Walter Reith; Jacques-Antoine Haefliger; Paolo Meda
Journal:  J Membr Biol       Date:  2012-06-23       Impact factor: 1.843

2.  Differential effects of HNF-1α mutations associated with familial young-onset diabetes on target gene regulation.

Authors:  Maria Galán; Carmen-Maria García-Herrero; Sharona Azriel; Manuel Gargallo; Maria Durán; Juan-Jose Gorgojo; Victor-Manuel Andía; Maria-Angeles Navas
Journal:  Mol Med       Date:  2010-12-15       Impact factor: 6.354

3.  Alx3-deficient mice exhibit decreased insulin in beta cells, altered glucose homeostasis and increased apoptosis in pancreatic islets.

Authors:  M Mirasierra; A Fernández-Pérez; N Díaz-Prieto; M Vallejo
Journal:  Diabetologia       Date:  2010-11-21       Impact factor: 10.122

4.  Glucose-dependent downregulation of glucagon gene expression mediated by selective interactions between ALX3 and PAX6 in mouse alpha cells.

Authors:  Mercedes Mirasierra; Mario Vallejo
Journal:  Diabetologia       Date:  2016-01-06       Impact factor: 10.122

5.  BMP-2 Induced Expression of Alx3 That Is a Positive Regulator of Osteoblast Differentiation.

Authors:  Takashi Matsumoto; Atsushi Yamada; Ryo Aizawa; Dai Suzuki; Masayuki Tsukasaki; Wataru Suzuki; Mutsuko Nakayama; Koutaro Maki; Matsuo Yamamoto; Kazuyoshi Baba; Ryutaro Kamijo
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

6.  Genetic and Molecular Basis of QTL of Diabetes in Mouse: Genes and Polymorphisms.

Authors:  Peng Gao; Yan Jiao; Qing Xiong; Cong-Yi Wang; Ivan Gerling; Weikuan Gu
Journal:  Curr Genomics       Date:  2008       Impact factor: 2.236

7.  Embryonic defence mechanisms against glucose-dependent oxidative stress require enhanced expression of Alx3 to prevent malformations during diabetic pregnancy.

Authors:  Patricia García-Sanz; Mercedes Mirasierra; Rosario Moratalla; Mario Vallejo
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.